CaNa2EDTA for improvement of radioimmunodetection and radioimmunotherapy with and 90Y-DTPA-Anti-CEA MAbs in nude mice bearing human colorectal cancer

Journal of Nuclear Medicine

Volumn 41, Issue 2, 2000, Pages 337-344

  Watanabe, Naoyuki ^a   Oriuchi, Noboru ^b   Endo, Keigo ^b   Inoue, Tomio ^b   Kuroki, Masahide ^b   Matsuoka, Yuji ^b   Tanada, Shuji ^b   Murata, Hajime ^b   Kim, E Edmund ^b   Sasaki, Yasuhito ^b  

^a NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^b NONE

Author keywords

111In; 90Y; Calcium disodium ethylenediaminetetraacetic acid; Radioimmunodetection; Radioimmunotherapy

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; EDETATE CALCIUM DISODIUM; MONOCLONAL ANTIBODY; PENTETATE INDIUM IN 111; YTTRIUM 90; DIAGNOSTIC AGENT; EDETIC ACID; INDIUM; YTTRIUM;

ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMAGE QUALITY; ISOTOPE LABELING; LUNG CARCINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIOACTIVITY; RADIOIMMUNOASSAY; RADIOIMMUNOTHERAPY; ANIMAL; CELL CULTURE; COLORECTAL TUMOR; IMMUNOLOGY; IN VITRO STUDY; NUDE MOUSE; SCINTISCANNING;

ANIMALS; ANTIBODIES, MONOCLONAL; CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; EDETIC ACID; FEMALE; HUMANS; INDIUM RADIOISOTOPES; MICE; MICE, NUDE; RADIOIMMUNODETECTION; RADIOIMMUNOTHERAPY; TUMOR CELLS, CULTURED; YTTRIUM RADIOISOTOPES;

EID: 0033621987     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Goldenberg DM. Future role of radiolabeled monoclonal antibodies in oncological diagnosis and therapy. Semin Nucl Med. 1989;19:332-339.
2. Hnatowich DJ, Childs RL, Lanteigne D, et al. The preparation of DTPA-coupled antibodies radiolabeled with metallic radionuclides: an improved method. J Immunol Methods. 1983;65:147-157.
3. Hnatowich DJ, Virzi F, Doherty PW. DTPA-coupled antibodies labeled with yttrium-90. J Nucl Med. 1985;26:503-509.
4. Mather SJ, Tolley DM, White GW. Labelling monoclonal antibodies with yttrium-90. Eur J Nucl Med. 1989;15:307-312.
5. Bischof Delaloye A, Delaloye B. Tumor imaging with monoclonal antibodies. Semin Nucl Med. 1995;25:144-164.
6. Breitz HB, Sullivan K, Nelp WB. Imaging lung cancer with radiolabeled antibodies. Semin Nucl Med. 1993;23:127-132.
7. 90Y-labeled monoclonal antibodies to carcinoembryonic antigen. Cancer Res. 1988;48:3270-3275.
8. Hnatowich DJ, Virzi F, Rusckowski M. Investigations of avidin and biotin for imaging applications. J Nucl Med. 1987;28:1294-1302.
9. Paganelli G, Riva P, Deleide G, et al. In vivo labelling of biotilated monoclonal antibodies by radioactive avidin: a strategy to increase tumor radiolocalization. Int J Cancer. 1988;2(suppl):121-125.
10. Paganelli G, Belloni C, Magnani P, et al. Two-step tumour targetting in ovarian cancer patients using biotinylated monoclonal antibodies and radioactive streptoavidin. Eur J Nucl Med. 1992;19:322-329.
11. Kalofonos HP, Rusckowski M, Siebecker DA, et al. Imaging of tumor in patients with indium-111-labeled biotin and streptavidin-conjugated antibodies: preliminary communication. J Nucl Med. 1990;31:1791-1796.
12. Esteban JM, Schlom J, Gansow OA, et al. New method for the chelation of indium-111 to monoclonal antibodies: biodistribution and imaging of athymic mice bearing human colon carcinoma xenografts. J Nucl Med. 1987;28:861-870.
13. 90Y from cyclic and acyclic ligand-antibody conjugates. Int J Rad Appl Instrum B. 1991;18:469-476.
14. 90Y-labeled B72.3 immunoconjugate (GYK-DTPA) in beagle dogs. Nucl Med Biol. 1993;20:559-570.
15. Mardirossian G, Wu C, Hnatowich DJ. The stability in liver homogenates of indium-111 and yttrium-90 attached to antibody via two popular chelators. Nucl Med Biol. 1993;20:65-74.
16. Kosmas C, Snook D, Gooden CS, et al. Development of humoral immune responses against a macrocyclic chelating agent (DOTA) in cancer patients receiving radioimmunoconjugates for imaging and therapy. Cancer Res. 1992;52: 904-911.
17. 90yttrium-labeled antiferritin for refractory Hodgkin's disease. Int J Radiat Oncol Biol Phys. 1989;17:815-821.
18. Klaassen CD. Toxicology. In: Goodman LS, Gilman AG, Rall TW, Nies AS, Taylor P, eds. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 8th ed. New York, NY: Pergamon Press; 1990;1592-1614.
19. 111indium-labeled human tumor cells. Cancer Lett. 1984;24:179-185.
20. 111In labeled monoclonal antibody with chelator administration to host nude mice. Eur J Nucl Med. 1987;12:573-575.
21. Stewart J, Hird V, Snook D, et al. Intraperitoneal yttrium-90-labeled monoclonal antibody in ovarian cancer. J Clin Oncol. 1990;8:1941-1950.
22. 90Y-labeled antibody uptake by human tumor xenografts and the effect of systemic administration of EDTA. Int J Radiat Oncol Biol Phys. 1994;28:1257-1265.
23. Kuroki M, Murakami M, Wakisaka M, et al. Epitopes predominantly retained on the carcinoenbryonic antigen molecules in plasma of patients with malignant tumors but not on those in plasma of normal individuals. Jpn J Cancer Res. 1992;83:505-514.
24. Watanabe N, Oriuchi N, Sugiyama S, Kuroki M, Matsuoka Y. Radioimmunoscintigraphy of colorectal cancer with technetium-99m-labeled murine anticarcinoembryonic antigen monoclonal antibody in athymic nude mice. Ann Nucl Med. 1994;8:23-30.
25. Hunter WM, Greenwood FC. Preparation of iodine-131 labeled growth hormone of high specific activity. Nature. 1962;194:495-496.
26. Mather SJ, Ellison D. Reduction-mediated technetium-99m labeling of monoclonal antibodies. J Nucl Med. 1990;31:692-697.
27. 111In for tumor localization [abstract]. J Nucl Med. 1969;10:343.
28. 111In for localization of recognized neoplastic disease [abstract]. J Nucl Med. 1970;11:328-329.
29. Takeda, S, Uchida T, Matsuzawa T. A comparative study on lysosomal accumulation of gallium-67 and indium-111 in Morris hepatoma 7316A. J Nucl Med. 1977;18:835-839.
30. 169Yb binding substances in tumor tissues and liver. Eur J Nucl Med. 1982;7:293-303.
31. 111In-labeled monoclonal antitumor antibodies in normal animals and nude mouse-human tumor models. Cancer Res. 1983;43:5347-5355.
32. Fairweather DS, Bradwell AR, Dykes PW, Vaughan AT, Watson-James SF, Chandler S. Improved tumour localization using indium-111 labelled antibodies. Br Med J. 1983;287:167-170.
33. Pimm MV, Perkins AC, Baldwin RW. Differences in tumour and normal tissue concentrations of iodine-and indium-labelled monoclonal antibody. II. Biodistribution studies in mice with human tumour xenografts. Eur J Nucl Med. 1985;11:300-304.